Background and Objectives. our objective was to study in more detail o
ur previous finding that intravenous droperidol inhibits pruritus indu
ced by epidural morphine. Methods. In a double blind study, 107 ASA I
or II patients undergoing cesarean section received epidural anesthesi
a with 150 mg (30 ml) of 0.5% bupivacaine with 1:200,000 epinephrine a
nd 2 mg of morphine hydrochloride in a single injection. They were ran
domly allocated to either receive (treated group, n = 54) or not recei
ve (control group, n = 53) an intravenous injection of 2.5 mg of drope
ridol just after delivery. During the postoperative period, the patien
ts were assessed for the occurrence and severity of pruritus or other
possible untoward symptoms. Pruritus was classified as absent, mild, m
oderate, or severe. Results. The incidence of pruritus in control grou
p was absent, 26.4%; mild, 39.6%; moderate, 28.3%; severe, 5.7%; for t
he treated group, the incidences were, respectively: 59.2; 27.8; 13.0;
and 0.0% (p = 0.0003; Mann-Whitney test). As for other side effects o
f morphine, nausea and vomiting had a similar incidence in the two gro
ups; urinary retention could not be analyzed because of bladder cathet
erization, and constipation, herpes labialis and clinical evidence of
respiratory depression were never observed. Droperidol produced a grea
ter incidence of somnolence (2% in control and 17% in treated group -
p < 0.02; Fisher's exact test), but it was never incapacitating. The i
ncidence of hypotension was similar in the two groups. Conclusion. Int
ravenous droperidol reduces the incidence and severity of pruritus cau
sed by epidural injection of morphine without inducing important side
effects.